Nicotine replacement therapy products Nicorette and NicoDerm CQ will drop duration-of-use limits and some warnings about risk from labeling, pioneering changes FDA opened the door for in April.
Smoking Cessation Labels Cleared Without Duration-Of-Use Limit
FDA approved labeling for Nicorette and NicoDerm CQ nicotine replacement therapies, removing some risk information that industry and the agency agree is outdated and unnecessarily restrictive.